Health

South Korea's Leading Hair Loss Treatment Company, AESMED Co., Ltd., to Participate in Cosmoprof Asia Hong Kong 2025

AESMED to Focus on Promoting the 1111 Hair Care Day Campaign SEOUL, South Korea, Oct. 28, 2025 /PRNewswire/ -- AESMED Co., Ltd., a leading hair loss treatment company inSouth Korea, announced its participation in Cosmoprof Asia Hong Kong 2025, the largest B2B international beauty trade fair inAs...

2025-10-28 19:37 866

Ping An Reports Significant Improvements in Operating Profit in 9M 2025, Life & Health NBV Robustly Increases 46.2% YoY

Net Profit Surges 45.4% YoY in 3Q 2025 HONG KONG, SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company", or the "Group", HKEX: 2318 / 82318; SSE: 601318) today announced its results for the nine months endedSeptember 30, 2025....

2025-10-28 18:02 1368

Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in China's Zhangshu City

BEIJING, Oct. 28, 2025 /PRNewswire/ -- China's Zhangshu City, a famed industrial hub of traditional Chinese medicine (TCM) for centuries, has actively promoted integration of tradition and innovation forChina's traditional medicines and medical treatment on its annual TCM fair.

2025-10-28 16:31 802

Xinhua Silk Road: Traditional Chinese medicine showcases its timeless magic

BEIJING, Oct. 28, 2025 /PRNewswire/ -- Under the night sky, Yongde Road Pedestrian Street is exceptionally bustling, where a vibrant Traditional Chinese Medicine (TCM) night market is unfolding. Niladri, an international student fromBangladesh studying at Shanghai Jiao Tong University, had an im...

2025-10-28 11:38 658

Standard Foods Announces Strategic Partnership and Investment in Hello Health to Strengthen the Bridge Between Digital Health and Nutrition in Southeast Asia.

SINGAPORE, Oct. 28, 2025 /PRNewswire/ -- Hello Health Group (HHG), Asia's leading digital health and wellness platform, andStandard Foods Group (SFG), a leading nutrition and health-related consumer goods company headquartered in Taiwan, are pleased to announce a strategic partnership, with SFG jo...

2025-10-28 10:00 1002

Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Fast Track Designation by FDA for the Treatment of PROC

SUZHOU, China, Oct. 28, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of advanced or...

2025-10-28 09:46 845

JSBio Strengthens Commitment to Power Cellular Agriculture Commercialization

Building on biopharma expertise, JSBio drives scalable innovation and partnerships to advance the cellular agriculture industry.  SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- JSBio, a leading cell culture media manufacturer and service provider in the APAC region, is deepening its commitment to cellu...

2025-10-28 09:00 1004

Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License Agreement with Institut du Cancer de Montpellier for Novel Onco-Metabolism Program

EPALINGES, Switzerland, Oct. 28, 2025 /PRNewswire/ -- Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics France, has exercised its exclusive option and entered into a worldwide license agreement with Institut du Cancer de Mon...

2025-10-28 08:00 794

Nippon Shinyaku Selects LifeSphere® Safety

Japan-based Nippon Shinyaku has chosen LifeSphere MultiVigilance as new case processing database TOKYO, Oct. 28, 2025 /PRNewswire/ -- ArisGlobal , an AI-first technology comp...

2025-10-28 07:00 1059

Vietnam Healthcare Summit 2025: Powering Transformation of Vietnam's Healthcare Landscape Through Innovation and Investment

HO CHI MINH CITY, Vietnam, Oct. 28, 2025 /PRNewswire/ -- Vietnam Innovators Digest successfully hosted the Vietnam Healthcare Summit 2025 under the theme  "Making Vietnam an Innovation Hub Through Healthcare", held at JW Marriott Hotel & Suites Saigon. The event gathered over200 healthcare leaders...

2025-10-28 01:31 1320

The WEMP Foundation and Rafa Nadal Foundation are joining together to Support Total Wellbeing of Children and Youth through Play

HONG KONG, Oct. 27, 2025 /PRNewswire/ -- The WEMP Foundation (WEMP, which stands for "Wellbeing", "EQ", "Mental Health", and "Parenting") and theRafal Nadal Foundation (RNF) are delighted to announce their alliance for supporting total wellbeingof children and youth around the world through Play....

2025-10-27 22:13 1154

Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., Oct. 27, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech developing a novel treatment for gout, today announced the successful completion o...

2025-10-27 21:00 823

Kolmar Korea Selected for Government-Led 'AI Factory' Initiative -- Driving Innovation in K-Beauty Manufacturing

* The only cosmetics company chosen by the Ministry of Trade, Industry and Resources for the "AI Factory" project * Enables agile, small-batch, multi-product production to meet diverse client needs in real time SEOUL, South Korea, Oct. 27, 2025 /PRNewswire/ -- Kolmar Korea

2025-10-27 20:30 4005

China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392)

Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous non-small cell lung cancer (sqNSCLC), an aggressive subtype of lung cancer Breakthrough Therapy designation will allow for an expedited development and regulatory review of gotistobart inChina Globa...

2025-10-27 19:00 917

Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025

-Multiple posters being presented on Ascletis' small molecule and peptide obesity programs -Full analysis of 28-day multiple ascending dose study of oral GLP-1R small molecule agonist ASC30 as a late-breaking poster as well as ASC30 once-monthly treatment formulation and once-quarterly maintenan...

2025-10-27 18:00 1147

Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials

SINGAPORE, Oct. 27, 2025 /PRNewswire/ -- Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streamline patient recruitment for oncology clinical trials, mar...

2025-10-27 13:22 1046

KLN Named Exclusive Distributor for Siemens Healthineers

Point-of-Care Testing Solutions in Hong Kong HONG KONG, Oct. 27, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) announces a strategic partnership between its healthcare subsidiary, KLN Medical Limited ('KLN Medical'), and global medical technology leader Siemens Hea...

2025-10-27 12:00 990

CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)

Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing BROADMEADOWS, AUSTRALIA, Oct. 27, 2025 /PRNewswire/ -- CSL

2025-10-27 11:23 1785

Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for Colorectal Cancer

SUZHOU, China, Oct. 27, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC P...

2025-10-27 09:51 883

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

SHANGHAI and HONG KONG, Oct. 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune dis...

2025-10-27 09:00 866
1 ... 13141516171819 ... 561